10% Stockholder Files Intent to Sell Over $1.1M in Shares Following Nasdaq Delisting Notice

summarizeSummary

A 10% stockholder intends to sell over $1.1 million in Tenaya Therapeutics shares, a significant transaction occurring shortly after the company received a Nasdaq delisting notice.

check_boxKey Events

• Intent to Sell Shares

  COLUMN GROUP III, LP, a 10% stockholder, filed a Form 144 to sell 1,408,910 shares of common stock.

• Significant Transaction Value

  The proposed sale has an approximate market value of $1.11 million.

• Follows Delisting Notice

  This intent to sell comes after Tenaya Therapeutics received a Nasdaq delisting notice on January 30, 2026, due to failing to meet the minimum bid price.

auto_awesomeAnalysis

COLUMN GROUP III, LP, a 10% stockholder, has filed a Form 144 indicating an intent to sell 1,408,910 shares of Tenaya Therapeutics common stock, valued at approximately $1.11 million. This proposed sale represents a notable portion of the company's market capitalization and comes shortly after the company received a Nasdaq delisting notice on January 30, 2026. The timing of this significant insider selling by an institutional investor, amidst the company's struggle to maintain its Nasdaq listing, could signal a lack of confidence and add further downward pressure on the stock.